Multiple Myeloma

Outcomes for Bacterial Meningitis in Patients With Multiple Myeloma

By

Ron Goldberg

Publish Date August 5, 2022

Researchers sought to determine the outcomes for patients with multiple myeloma who develop bacterial meningitis.

Measuring Circulating Tumor Cells at Diagnosis Can Improve Risk Stratification in Multiple Myeloma

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date August 3, 2022

Circulating tumor cell levels were an independent predictor of progression-free survival and overall survival.

Ocular Toxicity Appears Common With Belantamab Mafodotin in Advanced Multiple Myeloma

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date July 27, 2022

Researchers sought to determine whether ocular toxicity occurred in a significant number of patients with multiple myeloma treated with belantamab mafodotin.

A-Fib Linked to Worse Hospital Outcomes in Multiple Myeloma

Publish Date July 26, 2022

In stratified analysis, odds of all-cause mortality, hospital stay of more than five days higher for MM patients not using anticoagulation.

Microvesicles and Possible Implications for Patients With Multiple Myeloma

By

Vicki Moore, PhD

Publish Date July 19, 2022

Researchers sought to determine the implications of plasma levels of microvesicles in patients with multiple myeloma.